81 FR 39936 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 118 (June 20, 2016)

Page Range		39936-39937
FR Document		2016-14441

Federal Register, Volume 81 Issue 118 (Monday, June 20, 2016)

[Federal Register Volume 81, Number 118 (Monday, June 20, 2016)]
[Notices]
[Pages 39936-39937]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-14441]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 39937]]

amended (5 U.S.C. App), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Exploratory Studies of Smoking Cessation 
Interventions for People with Schizophrenia (R21/R33).
    Date: July 8, 2016.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Policy and Review, National Institute on Drug 
Abuse, NIH, Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 
20892-9550, (301) 451-3086, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: June 14, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-14441 Filed 6-17-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 118 / Monday, June 20, 2016 / Notices 39937

amended (5 U.S.C. App), notice is would constitute a clearly unwarranted Agenda: To review and evaluate grant
hereby given of the following meeting. invasion of personal privacy. applications.
The meeting will be closed to the Place: Embassy Suites at the Chevy Chase
Name of Committee: National Institute of Pavilion, 4300 Military Road NW.,
public in accordance with the Neurological Disorders and Stroke Special Washington, DC 20015.
provisions set forth in sections Emphasis Panel; NST–1 Member Conflict. Contact Person: Joanna Kubler-Kielb,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Date: June 16, 2016. Scientific Review Officer, Scientific Review
as amended. The grant applications and Time: 7:00 a.m. to 8:00 p.m. Branch, Eunice Kennedy Shriver National
the discussions could disclose Agenda: To review and evaluate grant Institute of Child Health and Human
confidential trade secrets or commercial applications. Development, NIH, 6710B Rockledge Drive,
property such as patentable material, Place: Wyndham Grand Chicago Room 2127D, Bethesda, MD 20892, (301)
Riverfront, 71 E. Wacker Drive, Chicago, IL 435–6916, kielbj@mail.nih.gov.
and personal information concerning 60601.
individuals associated with the grant This notice is being published less than 15
Contact Person: William Benzing, Ph.D.,
applications, the disclosure of which days prior to the meeting due to the timing
Scientific Review Administrator, Scientific
would constitute a clearly unwarranted limitations imposed by the review and
Review Branch, NINDS/NIH/DHHS,
funding cycle.
invasion of personal privacy. Neuroscience Center, 6001 Executive Blvd.,
Suite 3204, MSC 9529, Bethesda, MD 20892– (Catalogue of Federal Domestic Assistance
Name of Committee: National Institute on Program Nos. 93.864, Population Research;
Drug Abuse Special Emphasis Panel; 9529, 301–496–0660, benzingw@
mail.nih.gov. 93.865, Research for Mothers and Children;
Exploratory Studies of Smoking Cessation 93.929, Center for Medical Rehabilitation
Interventions for People with Schizophrenia This notice is being published less than 15 Research; 93.209, Contraception and
(R21/R33). days prior to the meeting due to the timing Infertility Loan Repayment Program, National
Date: July 8, 2016. limitations imposed by the review and Institutes of Health, HHS)
Time: 1:00 p.m. to 3:00 p.m. funding cycle.
Agenda: To review and evaluate grant (Catalogue of Federal Domestic Assistance Dated: June 14, 2016.
applications. Program Nos. 93.853, Clinical Research Michelle Trout,
Place: National Institutes of Health, Related to Neurological Disorders; 93.854, Program Analyst, Office of Federal Advisory
Neuroscience Center, 6001 Executive Biological Basis Research in the Committee Policy.
Boulevard, Rockville, MD 20852 (Telephone Neurosciences, National Institutes of Health, [FR Doc. 2016–14440 Filed 6–17–16; 8:45 am]
Conference Call). HHS)
Contact Person: Jose F. Ruiz, Ph.D., BILLING CODE 4140–01–P
Scientific Review Officer, Office of Dated: June 14, 2016.
Extramural Policy and Review, National Sylvia L. Neal,
Institute on Drug Abuse, NIH, Room 4228, Program Analyst, Office of Federal Advisory DEPARTMENT OF HEALTH AND
MSC 9550, 6001 Executive Blvd., Bethesda, Committee Policy. HUMAN SERVICES
MD 20892–9550, (301) 451–3086, ruizjf@ [FR Doc. 2016–14442 Filed 6–17–16; 8:45 am]
nida.nih.gov. National Institutes of Health
BILLING CODE 4140–01–P
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and National Heart, Lung, and Blood
Addiction Research Programs, National Institute; Notice of Closed Meetings
Institutes of Health, HHS) DEPARTMENT OF HEALTH AND
HUMAN SERVICES Pursuant to section 10(d) of the
Dated: June 14, 2016. Federal Advisory Committee Act, as
Natasha M. Copeland, National Institutes of Health amended (5 U.S.C. App.), notice is
Program Analyst, Office of Federal Advisory hereby given of the following meetings.
Committee Policy. Eunice Kennedy Shriver National The meetings will be closed to the
[FR Doc. 2016–14441 Filed 6–17–16; 8:45 am] Institute of Child Health & Human public in accordance with the
BILLING CODE 4140–01–P
Development; Notice of Closed provisions set forth in sections
Meeting 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Pursuant to section 10(d) of the as amended. The grant applications and
DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as the discussions could disclose
HUMAN SERVICES amended (5 U.S.C. App.), notice is confidential trade secrets or commercial
hereby given of the following meeting. property such as patentable material,
National Institutes of Health and personal information concerning
The meeting will be closed to the
National Institute of Neurological public in accordance with the individuals associated with the grant
Disorders and Stroke; Notice of Closed provisions set forth in section 552b(c)(4) applications, the disclosure of which
Meeting and 552b(c)(6), Title 5 U.S.C., as would constitute a clearly unwarranted
amended. The grant applications and invasion of personal privacy.
Pursuant to section 10(d) of the the discussions could disclose Name of Committee: National Heart, Lung,
Federal Advisory Committee Act, as confidential trade secrets or commercial and Blood Institute Special Emphasis Panel;
amended (5 U.S.C. App.), notice is property such as patentable material, NHLBI Conference Grant Review (R13).
hereby given of the following meeting. and personal information concerning Date: July 12, 2016.
The meeting will be closed to the individuals associated with the grant Time: 8:30 a.m. to 5:00 p.m.
public in accordance with the applications, the disclosure of which Agenda: To review and evaluate grant
provisions set forth in sections applications.
asabaliauskas on DSK3SPTVN1PROD with NOTICES

would constitute a clearly unwarranted
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Place: National Institutes of Health, 6701
invasion of personal privacy. Rockledge Drive, Room 7184, Bethesda, MD
as amended. The grant applications and
the discussions could disclose Name of Committee: Eunice Kennedy 20892 (Telephone Conference Call).
Shriver National Institute of Child Health Contact Person: YingYing Li-Smerin, MD,
confidential trade secrets or commercial and Human Development Initial Review Ph.D., Scientific Review Officer, Office of
property such as patentable material, Group, Function, Integration, and Scientific Review/DERA, National Heart,
and personal information concerning Rehabilitation Sciences Subcommittee. Lung, and Blood Institute, 6701 Rockledge
individuals associated with the grant Date: June 24, 2016. Drive, Room 7184, Bethesda, MD 20892–
applications, the disclosure of which Time: 8:00 a.m. to 5:00 p.m. 7924, 301–435–0277, lismerin@nhlbi.nih.gov.

VerDate Sep<11>2014 17:05 Jun 17, 2016 Jkt 238001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\20JNN1.SGM 20JNN1

Document Created: 2016-06-18 00:09:01
Document Modified: 2016-06-18 00:09:01

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		July 8, 2016.
FR Citation		81 FR 39936

81 FR 39936 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 118 (June 20, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health